Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Other Gross PP&E Adjustments (2016 - 2025)

Integra Lifesciences Holdings' Other Gross PP&E Adjustments history spans 16 years, with the latest figure at $740.4 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 13.86% year-over-year to $740.4 million; the TTM value through Dec 2025 reached $740.4 million, up 13.86%, while the annual FY2025 figure was $740.4 million, 13.86% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $740.4 million at Integra Lifesciences Holdings, up from -$165.1 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $740.4 million in Q4 2025 and bottomed at -$218.1 million in Q1 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$166.2 million (2022), against an average of $16.6 million.
  • The largest annual shift saw Other Gross PP&E Adjustments tumbled 55.26% in 2022 before it rose 19.9% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $528.1 million in 2021, then dropped by 8.62% to $482.6 million in 2022, then rose by 12.39% to $542.3 million in 2023, then increased by 19.9% to $650.3 million in 2024, then increased by 13.86% to $740.4 million in 2025.
  • Per Business Quant, the three most recent readings for IART's Other Gross PP&E Adjustments are $740.4 million (Q4 2025), -$165.1 million (Q3 2025), and -$190.3 million (Q2 2025).